Tackling the VEGFR-3 signaling axis in obesity has resulted in dichotomous effects on adipose inflammation with some studies worsening and others improving metabolism (Karaman et al., 2015, 2016; Chakraborty et al., 2019). Here, FLT4 is linked to obesity due to melanocortin 4 receptor deficiency.